Missing/wrong data?
Log in to edit
Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics
article published in 2011
Author/s
author: Torsten Haferlach, Claudia Haferlach, Susanne Schnittger
Work details
Publication date
April 15, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.